RTSL (Rapid Therapeutic Science Laboratories) ROCE %: 0.00% (As of Jun. 2023)

What is Rapid Therapeutic Science Laboratories ROCE %?

Rapid Therapeutic Science Laboratories RTSL ROCE % is 0.00% as of Jun. 2023.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rapid Therapeutic Science Laboratories's annualized ROCE % for the quarter that ended in Jun. 2023 was 0.00%.

Rapid Therapeutic Science Laboratories (OTCPK:RTSL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rapid Therapeutic Science Laboratories ROCE % Related Terms

Rapid Therapeutic Science Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Rapid Therapeutic Science Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Therapeutic Science Laboratories ROCE % Chart

Rapid Therapeutic Science Laboratories Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

0.00

Rapid Therapeutic Science Laboratories Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

Rapid Therapeutic Science Laboratories ROCE % Calculation

Rapid Therapeutic Science Laboratories's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	0.101	/	( ( (2.2 - 3.053)	+	(2.255 - 4.966) )	/ 2 )
	=	0.101	/	( (-0.853	+	-2.711)	/ 2 )
	=	0.101	/	-1.782
	=	-5.67 %

Rapid Therapeutic Science Laboratories's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	0.428	/	( ( (2.034 - 4.463)	+	(2.074 - 4.426) )	/ 2 )
	=	0.428	/	( ( -2.429	+	-2.352 )	/ 2 )
	=	0.428	/	-2.3905
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 0.00% mean?

Rapid Therapeutic Science Laboratories (RTSL) has a ROCE % of 0.00% as of Jun. 2023.

Is Rapid Therapeutic Science Laboratories' ROCE % too high?

Rapid Therapeutic Science Laboratories' current ROCE % is 0.00%.

How does Rapid Therapeutic Science Laboratories' ROCE % compare to VRAYQ and NNMX?

Rapid Therapeutic Science Laboratories' ROCE % of 0.00% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Diversified Financial Services company?

A good ROCE % depends on the Diversified Financial Services industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. Rapid Therapeutic Science Laboratories's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Rapid Therapeutic Science Laboratories stock overvalued right now?

Rapid Therapeutic Science Laboratories (RTSL) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Rapid Therapeutic Science Laboratories (RTSL), the current ROCE % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rapid Therapeutic Science Laboratories Business Description

Industry Financial Services Diversified Financial Services

Comparable Companies VRAYQ NNMX ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN.PODD OCSE:DEMANT BRKR

Address 558 County Road 472, De Leon, TX, USA, 76444

Website https://www.rtslco.com

Rapid Therapeutic Science Laboratories Inc currently has no operations and operates as a blank check company.